| PRP |
Moderate and growing evidence for androgenetic alopecia |
Selected patients with early to moderate hair thinning and active follicles |
Results vary; protocols differ and maintenance sessions may be required |
| GFC |
Emerging evidence; research is still developing |
Selected patients seeking an injectable regenerative approach |
Studies use different preparations and protocols; long-term evidence remains limited |
| LLLT |
Growing clinical evidence, particularly for androgenetic alopecia |
Early to moderate thinning where a non-invasive option is preferred |
Requires consistent sessions; results depend on device, wavelength and treatment schedule |
| QR678 |
Promising but more limited evidence compared with established hair-loss approaches |
Selected patients with early or moderate thinning |
Some studies have design limitations, and treatment response can vary |